![logo](/logos/185750.KS.webp)
Chong Kun Dang Pharmaceutical Corp.
KRX:185750.KS
111,200 (KRW) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Chong Kun Dang Pharmaceutical Corp. |
Symbool | 185750.KS |
Munteenheid | KRW |
Prijs | 110,600 |
Beurswaarde | 1,396,794,607,600 |
Dividendpercentage | 1.01% |
52-weken bereik | 81,714.3 - 136,500 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Young-Joo Kim |
Website | https://www.ckdpharm.com |
An error occurred while fetching data.
Over Chong Kun Dang Pharmaceutical Corp.
Chong Kun Dang pharmaceutical Corp. engages in the manufacturing, marketing, and selling of medicines in South Korea and internationally. It provides prescription drugs for anti-hypertension, anti-hyperlipidemia, and anti-diabetics; over-the-counter drugs, such as Penzal, Prefemine, and Modcol, as well as consumer health products, such as insecticides, hair dye, etc.; and healthcare
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (KRW)
Cijfers zijn in miljoenen (KRW)